rs55666134

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001277115.2(DNAH11):​c.5490G>A​(p.Leu1830Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.142 in 1,610,424 control chromosomes in the GnomAD database, including 17,294 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1229 hom., cov: 32)
Exomes 𝑓: 0.14 ( 16065 hom. )

Consequence

DNAH11
NM_001277115.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.377

Publications

15 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 7-21683813-G-A is Benign according to our data. Variant chr7-21683813-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 93691.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.377 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.154 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.5490G>A p.Leu1830Leu synonymous_variant Exon 32 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.5490G>A p.Leu1830Leu synonymous_variant Exon 32 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5

Frequencies

GnomAD3 genomes
AF:
0.117
AC:
17819
AN:
152060
Hom.:
1230
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0420
Gnomad AMI
AF:
0.139
Gnomad AMR
AF:
0.101
Gnomad ASJ
AF:
0.159
Gnomad EAS
AF:
0.141
Gnomad SAS
AF:
0.111
Gnomad FIN
AF:
0.155
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.157
Gnomad OTH
AF:
0.119
GnomAD2 exomes
AF:
0.129
AC:
31967
AN:
247102
AF XY:
0.132
show subpopulations
Gnomad AFR exome
AF:
0.0372
Gnomad AMR exome
AF:
0.0725
Gnomad ASJ exome
AF:
0.153
Gnomad EAS exome
AF:
0.141
Gnomad FIN exome
AF:
0.157
Gnomad NFE exome
AF:
0.156
Gnomad OTH exome
AF:
0.132
GnomAD4 exome
AF:
0.145
AC:
211014
AN:
1458246
Hom.:
16065
Cov.:
31
AF XY:
0.144
AC XY:
104462
AN XY:
725222
show subpopulations
African (AFR)
AF:
0.0350
AC:
1170
AN:
33418
American (AMR)
AF:
0.0764
AC:
3396
AN:
44464
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
4075
AN:
25968
East Asian (EAS)
AF:
0.140
AC:
5549
AN:
39646
South Asian (SAS)
AF:
0.109
AC:
9349
AN:
85498
European-Finnish (FIN)
AF:
0.157
AC:
8344
AN:
53246
Middle Eastern (MID)
AF:
0.115
AC:
662
AN:
5748
European-Non Finnish (NFE)
AF:
0.153
AC:
170290
AN:
1110014
Other (OTH)
AF:
0.136
AC:
8179
AN:
60244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
9477
18955
28432
37910
47387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6002
12004
18006
24008
30010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.117
AC:
17820
AN:
152178
Hom.:
1229
Cov.:
32
AF XY:
0.117
AC XY:
8688
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0420
AC:
1747
AN:
41552
American (AMR)
AF:
0.101
AC:
1539
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.159
AC:
553
AN:
3468
East Asian (EAS)
AF:
0.141
AC:
732
AN:
5182
South Asian (SAS)
AF:
0.111
AC:
535
AN:
4818
European-Finnish (FIN)
AF:
0.155
AC:
1642
AN:
10568
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.157
AC:
10662
AN:
67978
Other (OTH)
AF:
0.118
AC:
250
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
779
1558
2338
3117
3896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.142
Hom.:
5828
Bravo
AF:
0.109
Asia WGS
AF:
0.123
AC:
427
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Apr 05, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu1830Leu in exon 32 of DNAH11: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 15.0% (1240/8258) of European American chromosomes from a broad population by the NHLBI Exome Seq uencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs55666134). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary ciliary dyskinesia 7 Benign:1
Oct 29, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
2.0
DANN
Benign
0.64
PhyloP100
0.38
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55666134; hg19: chr7-21723431; COSMIC: COSV60957464; API